~~<i id='DC75007F0A'><strike id='DC75007F0A'><tt id='DC75007F0A'><pre id='DC75007F0A'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

leisure time

author：fashion 2025-08-12 06:42:45 - browse：6

The Food and Drug Administration on Thursday approved a gene therapy to treat people with hemophilia A, an inherited and rare bleeding disorder.

The treatment, called Roctavian, is made by BioMarin Pharmaceutical. It was first approved in Europe in August 2022.

Roctavian is a one-time therapy that, in clinical trials, dramatically reduced bleeding episodes and helped patients live without the blood transfusions used to treat the disease. The FDA first rejected Roctavian in 2020, asking BioMarin to amass more data on its safety and long-term durability, and then delayed its decision again to account for additional evidence.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Ed Silverman on new gene therapies, biosimilars, coffee, and more

leisure time

hotspot

Wikipedia

focus

Wikipedia

hotspot

AdobeHospitals,pharmacies,andotherhealthcareprovidersaregettingstuckinaninsuranceprocessinglogjamaft

WSS

Obesity drugs seen as possible treatment for liver disease MASH

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

With psoriasis trial ahead, Alumis raises $259 million

R1 RCM gets $5.8 billion buyout offer from private equity firm

hotspot

leisure time

leisure time

DIEP, the 'gold standard' of breast reconstruction, is under threat

With competition flaring, obesity drug hits goal in liver disease study

How to save PrEP access — and even expand it

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

Wildfire smoke exposes gaps in outdoor worker protections

STAT readers on older presidents, polypills, Medicare, and more

State Dept. review finds Biden bears some blame for Afghanistan failures

Medicare inequities exacerbate Puerto Rico’s health disparities

The high cost of giving birth even with insurance

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

hotspot

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

IVF, abortion rights issues kick off Biden’s State of the Union

Sen. Paul opposes bill to ban Chinese biotechs

Antivenom research: Lessons from HIV applied in search for universal antidote

Just how do doctors, lawmakers, and the public define abortion?

Wikipedia

focus

Wikipedia

hotspot